Pacific Biosciences

PACB Small Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

$1.34

-0.74% today

52W: $0.85 – $2.73

52W Low: $0.85 Position: 26.1% 52W High: $2.73

🔗 Compare Brokers

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

—

Forward Price/Earnings

P/S Ratio

2.53x

Price-to-Sales

EV/EBITDA

—

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$404.7M

Market Capitalization

Revenue Growth

13.8%

YoY Revenue Growth

Profit Margin

—

Net profit margin

ROE

-213.45%

Return on Equity

Beta

2.33

Market sensitivity

Short Interest

15.58%

% of float sold short

Avg. Volume

7,020,467

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

6 analysts

Avg. Price Target

$2.58

+92.79% upside

Target Range

$1.50 – $3.00

About the Company

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, the company

Sector: Healthcare Industry: Medical Devices Country: United States Employees: 485 Exchange: NMS